Skip to main content
Have a personal or library account? Click to login
Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance Cover

Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance

Acta Pharmaceutica
Volume 59 (2009): Issue 2 (June 2009)
By:  and    
Open Access
|Jun 2009
References

References

  1. J. W. Wiechers, The barrier functions of the skin in relation to percutaneous absorption of drugs,11 (1989) 185--198.
    Search in Google Scholar
  2. D. C. Monkhouse and A. S. Huq, Transdermal drug delivery - problems and promises,14 (1988) 183--203.
    Open DOISearch in Google Scholar
  3. M. B. Brown, G. P. Martin, S. A. Jones and F. K. Akomeah, Dermal and transdermal drug delivery systems: Current and future prospects,13 (2006) 175--187; DOI: 10.1080/10717540500455975.
    Open DOISearch in Google Scholar
  4. B. T. Kurihara, W. R. Good, S. Feusullin and C. Signor, Skin compatibility of transdermal drug delivery system,15 (1991) 271--278; DOI: 10.1016/0168-3659(91)90119-X.
    Open DOISearch in Google Scholar
  5. T. Furuishi, S. Oda, H. Saito, T. Fukami, T. Suzuki and K. Tomono, Effect of permeation enhancers on thepercutaneous absorption of pentazocine,30 (2007) 1350--1353.
    Search in Google Scholar
  6. V. Agarwal and B. Mishra, Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine,25 (1999) 701--709; DOI: 10.1081/DDC-100102229.
    Open DOISearch in Google Scholar
  7. M. Bhattacharyya, S. C. Mandal, B. Sa and B. K. Gupta, Studies on controlled release formulations of pentazocine hydrochloride,20 (1994) 1613--1629; DOI: 10.3109/03639049409050202.
    Open DOISearch in Google Scholar
  8. C. Valenta and B. G. Auner, The use of polymers for dermal and transdermal delivery,58 (2004) 279--289; DOI: 10.1016/j.ejpb.2004.02.017.
    Open DOISearch in Google Scholar
  9. , USP Convention, Rockville 2002, pp. 2018.
    Search in Google Scholar
  10. P. R. P. Verma and S. S. Iyer, Transdermal delivery of propranolol using mixed grades of eudragit: design andandevaluation,26 (2000) 471--476; DOI: 10.1081/DDC-100101257.
    Open DOISearch in Google Scholar
  11. A. R. Chandak and P. R. P. Verma, Development and evaluation of HPMC based matrices for transdermal patches of tramadol,25 (2008) 13--30; DOI: 10.1080/1060133-0701885066.
    Search in Google Scholar
  12. M. Man, C. Chang, P. H. Lee, C. T. Broman and G. W. Cleary, New improved paddle method for determining thedrug release profiles of transdermal delivery systems,27 (1993) 59--68; DOI: 10.1016/0168-3659(93)90057-C.
    Open DOISearch in Google Scholar
  13. B. Berkowitz and E. L. Way, Metabolism and excretion of pentazocine in man,10 (1969) 681--689.
    Open DOISearch in Google Scholar
  14. , (Ed. A. C. Moffat), 2ed., Pharmaceutical Press, London 1986, pp. 860--861.
    Search in Google Scholar
  15. S. Wartewig and R. H. H. Neubert, Pharmaceutical applications of Mid-IR and Raman spectroscopy,57 (2005) 1144--1170; DOI: 10.1016/j.addr.2005.01.022.
    Open DOISearch in Google Scholar
  16. T. D. Wilson,, in(Ed. K. Florey), Vol. 13, Pharmaceutical Press, London 1984, pp. 361--416.
    Open DOISearch in Google Scholar
  17. R. K. Verma and S. Garg, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations,35 (2004) 449--458; DOI:10.1016/j.jpba.2004.01.012.
    Open DOISearch in Google Scholar
  18. R. C. Mundargi, S. A. Patil, S. A. Agnihotri and T. M. Aminabhavi, Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol,33 (2007) 79--90; DOI: 10.1080/03639040600975030.
    Open DOISearch in Google Scholar
  19. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers,15 (1983) 25--35; DOI: 10.1016/0378-5173(83) 90064-9.
    Search in Google Scholar
  20. L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease,95 (2004) 521--533; DOI: 10.1016/j.jconrel.2003.12.018.
    Open DOISearch in Google Scholar
  21. S. Mutalik and N. Udupa, Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations,93 (2004) 1577--1594; DOI: 10.1002/jps. 20058.
    Search in Google Scholar
  22. U. D. Rohr, R. Altenburger and T. Kissel, Pharmacokinetics of the transdermal reservoir membrane system delivering β-estradiol:correlation,15 (1998) 877--882.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10007-009-0014-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian
Page range: 171 - 186
Published on: Jun 29, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
pentazocine,
transdermal drug delivery,
Cygnus' sandwich patch holder,
in vitro characterization,
in vivo evaluation
Related subjects:
Pharmacy,
Pharmacy, other

© 2009 Priya Prasad Verma, Ashok Chandak, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 59 (2009): Issue 2 (June 2009)
Previous article
Next article